From the Guidelines
Evaluation of elevated ferritin above 400 ng/mL without blood count or liver function abnormalities should begin with a thorough clinical history and targeted testing, prioritizing the assessment of serum iron parameters, including transferrin saturation and serum ferritin, as recommended by the EASL clinical practice guidelines on haemochromatosis 1. To evaluate elevated ferritin levels, the following steps should be taken:
- Rule out common causes like alcohol consumption, obesity, metabolic syndrome, and inflammatory conditions
- Order an iron panel including serum iron, total iron binding capacity (TIBC), and transferrin saturation to distinguish between iron overload and inflammatory causes
- If transferrin saturation is elevated (>45%), genetic testing for hereditary hemochromatosis (HFE gene mutations) is recommended, as suggested by the American Association for the Study of Liver Diseases 1
- For patients with normal transferrin saturation, consider inflammatory markers like C-reactive protein and erythrocyte sedimentation rate to identify inflammation as the cause
- Additional testing may include hemoglobin A1C, lipid panel, and hepatitis serologies
- In some cases, MRI of the liver to measure iron content or liver biopsy may be necessary if iron overload is suspected despite normal initial testing, as recommended by the 2011 practice guideline by the American Association for the Study of Liver Diseases 1 This approach helps differentiate between true iron overload conditions requiring treatment and benign or secondary causes of hyperferritinemia that may need different management strategies. Key considerations in the evaluation and management of elevated ferritin levels include:
- The concentration of serum iron and transferrin or total iron binding capacity can provide additional information for the differential diagnosis, as noted in the EASL clinical practice guidelines on haemochromatosis 1
- Measuring hepcidin is not recommended, as stated in the EASL clinical practice guidelines on haemochromatosis 1
- Individuals with a positive first-degree family history of haemochromatosis should also be tested by HFE genotyping with appropriate genetic counselling, as recommended by the EASL clinical practice guidelines on haemochromatosis 1
From the Research
Evaluating Elevated Ferritin Levels
To evaluate elevated ferritin levels above 400 without any blood changes and no LFT change, several factors should be considered:
- Ferritin levels can be influenced by various conditions, including iron storage disease, inflammation, and chronic diseases such as heart failure 2.
- Transferrin saturation (TSAT) and serum iron levels can provide additional information on iron status, and may be more informative than ferritin levels alone in certain cases 2, 3.
- The relationship between serum ferritin levels and total body iron stores is not always strong, and can be influenced by factors such as the presence of inflammatory conditions 4.
Diagnostic Criteria
The following diagnostic criteria can be used to evaluate elevated ferritin levels:
- Serum ferritin level: elevated above 400 ng/mL
- Transferrin saturation (TSAT): may be normal or elevated
- Serum iron level: may be normal or elevated
- Other laboratory tests, such as complete blood count (CBC) and liver function tests (LFTs), may be normal or show non-specific changes.
Clinical Considerations
Clinical considerations when evaluating elevated ferritin levels include:
- Presence of chronic diseases, such as heart failure, chronic kidney disease, or cancer, which can influence iron metabolism and ferritin levels 5, 2.
- Presence of inflammatory conditions, such as rheumatoid arthritis or chronic infections, which can increase ferritin levels 5, 4.
- Use of medications, such as nonsteroidal anti-inflammatory drugs (NSAIDs), which can influence iron absorption and ferritin levels 5.
Limitations of Current Evidence
There are limited studies that specifically address the evaluation of elevated ferritin levels above 400 without any blood changes and no LFT change. Most studies focus on the diagnosis and management of iron deficiency or iron overload, rather than elevated ferritin levels in the absence of other abnormalities 5, 4, 2, 6, 3.